Enbrel and Weight decrease neonatal - a phase IV clinical study of FDA data

Summary:

Weight decrease neonatal is reported as a side effect among people who take Enbrel (etanercept), especially for people who are male, 0-1 old, have been taking the drug for 5 - 10 years also take Methyldopa, and have High blood pressure.

The phase IV clinical study analyzes which people have Weight decrease neonatal when taking Enbrel. It is created by eHealthMe based on reports of 662,905 people who have side effects when taking Enbrel from the FDA, and is updated regularly.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.

What is Weight decrease neonatal?

Weight decrease neonatal is found to be associated with 25 drugs and 115 conditions by eHealthMe. Check the latest studies of Weight decrease neonatal.

On Jun, 21, 2026

662,905 people reported to have side effects when taking Enbrel.
Among them, 11 people (0.0%) have Weight decrease neonatal.

Could Enbrel cause Weight decrease neonatal?

Among these 11 people:

How long have people been on Enbrel when they have Weight decrease neonatal? *

What is the gender of people who have Weight decrease neonatal when taking Enbrel? *

female: 0.0 %
male: 100 %

What is the age of people who have Weight decrease neonatal when taking Enbrel? *

What are other drugs people take besides Enbrel? *

What are other side effects people have besides Weight decrease neonatal? *

Dehydration (dryness resulting from the removal of water): 7 people, 63.64%
Urinary Tract Infection: 7 people, 63.64%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 7 people, 63.64%
Bacteraemia (presence of bacteria in the blood): 6 people, 54.55%
Premature Baby: 3 people, 27.27%
Drug Exposure During Pregnancy: 3 people, 27.27%
Jaundice Neonatal (yellowing of skin in neonate): 3 people, 27.27%
Blood Glucose Decreased: 2 people, 18.18%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 18.18%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 2 people, 18.18%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 3 people, 27.27%
High Blood Pressure: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and have Weight decrease neonatal?

- Check whether Weight decrease neonatal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enbrel:

Enbrel (664,678 reports)

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight decrease neonatal:

Weight decrease neonatal (25 drugs)

Browse all the conditions that are associated with Weight decrease neonatal:

Weight decrease neonatal (115 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.